Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis.
A new vaccination strategy is urgently needed for improved control of the global tuberculosis (TB) epidemic. Using a mouse aerosol Mycobacterium tuberculosis challenge model, we investigated the protective efficacy of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG (ΔmmaA4BCG) formulated in...
Main Authors: | Steven C Derrick, Dee Dao, Amy Yang, Kris Kolibab, William R Jacobs, Sheldon L Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3307709?pdf=render |
Similar Items
-
Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.
by: Dee N Dao, et al.
Published: (2008-06-01) -
Tuberculosis vaccine strain <it>Mycobacterium bovis </it>BCG Russia is a natural <it>recA </it>mutant
by: Böttger Erik C, et al.
Published: (2008-07-01) -
Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01) -
Disseminated Mycobacterium bovis Infection after BCG Vaccination
by: Shahla Afshar Paiman, et al.
Published: (2006-09-01) -
Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)